Rehydra+ Wellness Review: The $119 Month You Cannot Buy

Rehydra+ Wellness (rehydraplus.com) advertises compounded semaglutide memberships from $119 a month and tirzepatide from $169. Both numbers are arithmetically honest and neither is purchasable. Every GLP-1 membership it sells is a six-month contract described, in its own words on two separate surfaces, as non-cancelable.¹

That single term reorganises everything else about this program, so we are going to start there rather than bury it.

What you are actually committing to

Multiply the advertised monthly figure by six and you get the real cheque. Semaglutide runs $714 at the lowest tier (0.25 and 0.5 mg), $1,014 in the middle (0.75 and 1.0 mg) and $1,374 at the top (1.7 and 2.5 mg). Tirzepatide runs $1,014, $1,734 and $2,514 across its three tiers.

There is no month-to-month membership rung anywhere in the catalogue. Not a more expensive one, not a hidden one — the option does not exist. So "from $119 a month" describes a division, not a purchase. Anyone publishing that figure without the six-month term attached is publishing a price that cannot be bought for one month, which is the specific reason we hold every filed figure to the month-to-month rung.

The six-month term also removes the exit that makes a GLP-1 program tolerable if it does not suit you. Roughly a fifth to a third of people stop early because of gastrointestinal effects or because the response is not there — see semaglutide side effects for what the trials actually report. On a cancel-anytime plan that costs you one month. Here it costs you the balance of six.

The one thing you can cancel

Rehydra+ does sell GLP-1 outside the membership, as one-time supply packs, and this is where the honest comparison lives.

Semaglutide supply packs run $149 for four weeks at 0.25 mg, rising through $179, $199 and $269 to $289 at 2.5 mg. Tirzepatide runs $219 at 2.5 mg, $249, $319, $449, $629 and $649 at 15 mg. Eight- and twelve-week packs are available at roughly proportional prices.

These are purchases, not subscriptions: you buy four weeks and you are done. Against the Tier 1 membership at $119 a month, the equivalent supply pack is $149 — so the flexibility premium is about $30 per four weeks, or roughly 25%. That is a perfectly reasonable price for not signing a six-month contract, and if you were going to use this provider at all, the supply pack is the version of it we would price.

Note the unit: these packs are sold by supply length, not billing cadence, and four weeks is not a month. Twelve of them is not a year — see Vyvron for the same arithmetic in its more common form.

What is not disclosed

The pharmacy is never named. It is referred to only as a pharmacy partner, which means the check at the centre of our provider checklist cannot be performed at all.

The states are never named either. The about page says the company serves patients in 20 states and no page anywhere lists which twenty. The state names that do appear on the site belong to a checkout dropdown containing all 50, which is a form control rather than a coverage claim.

Three clinicians are named — a medical director and two associated prescribers — with no NPIs published, so none can be checked against the national provider registry.

The site displays a pharmacy-certification badge. On close inspection it is a self-hosted image file linking to a keyword search rather than to a seal record, and no seal identifier appears anywhere on the site. We record that as unverified rather than false: the certification may well be real, but the badge as published does not prove it, and a badge that cannot be resolved to a record is decoration.

The catalogue is broader than the marketing

Rehydra+ runs on a conventional e-commerce cart, and the cart contains more than GLP-1s. It sells testosterone therapy as an ordinary product SKU at $399 for ten weeks. It sells BPC-157, KPV and tesamorelin in oral formulations alongside injectable ones, and oral bioavailability for those peptides is not established — an oral version of an injectable peptide is a different product with a different, and largely unevidenced, delivery question, not a needle-free convenience. It also carries NAD+ across three routes, sermorelin, MOTS-c, GHK-Cu and various blends.

None of that is illegal and none of it is our subject here, but a cart that lets you add a hormone to a basket next to a compounded GLP-1 sets a different bar for the clinical review you should expect, and there is no NPI on the site with which to judge it.

The regulatory screen

The trading name, the shortened brand stem and the legal entity each returned zero company-column matches in the FDA's live warning-letter index in August 2026, in a pass whose positive control correctly returned a known 2026 letter for an unrelated seller.² That is a real clean result and we are not going to blur it: Rehydra+ has no FDA warning letter on file. The problems with this provider are contractual and evidentiary, not enforcement history.

Two further terms worth knowing before you enter a card. There are no returns or refunds on prescription or compounded medication once shipped. And because the site is a cart rather than an intake, you pay for the product at checkout before a provider reviews you, with the refund policy silent on what happens if you are declined.

Where it lands on value

The advertised numbers put Rehydra+ near the bottom of the sticker-price field. The purchasable numbers do not. A $714 minimum commitment for the cheapest semaglutide tier is more than a full year at Pepti's $99 a month costs for six months, and roughly what Trellis Vitality charges for five months month-to-month with a named pharmacy behind it.

If you want to use Rehydra+, buy the four-week supply pack and re-buy it, which keeps you at $149 to $289 for semaglutide with the exit intact. Do not enter the membership on the strength of the monthly figure. Compare the alternatives on the cheapest semaglutide board and the cheapest GLP-1 over twelve months, and read the sourced background in our research library.